SLU-PP-332 is a small molecule that has drawn attention as a possible "exercise in a pill" candidate. It does not replace training, but it does activate some of the same gene programs that exercise turns on.
Origin and Classification
SLU-PP-332 was developed at Saint Louis University, which is where the "SLU" in the name comes from. It is a small molecule, not a peptide, even though it often appears alongside peptides in metabolic research discussions.
Its formal description is a pan-agonist of the estrogen-related receptors, meaning it activates all three forms — ERR-alpha, ERR-beta, and ERR-gamma. ERRs are nuclear receptors, a class of proteins that bind directly to DNA and switch genes on or off.
How the Mechanism Works
Despite the name, ERRs are not driven by estrogen. They are "orphan" receptors that share structural features with the estrogen receptor family but have their own job — regulating energy metabolism. When activated, they turn on genes for mitochondrial biogenesis, fatty acid oxidation, and oxidative phosphorylation.
These are the same gene programs that endurance exercise activates. By directly binding ERRs, SLU-PP-332 mimics part of the transcriptional response to training without the actual physical activity. This is why some researchers describe the compound as an exercise mimetic.
Preclinical Findings
Most of what we know comes from mouse studies. Billon and colleagues (2023) reported that obese mice given SLU-PP-332 showed dose-dependent improvements in running endurance, fat oxidation, and several metabolic parameters. Treated mice ran longer on a treadmill and burned more fat at rest than untreated controls.
Other groups have explored its effects on cardiac and skeletal muscle metabolism, age-related metabolic decline, and obesity models. Across these studies, the consistent theme is improved mitochondrial output and better fuel handling.
Important caveat — SLU-PP-332 has not entered human clinical trials. All published findings come from cell culture and rodent models, which often translate poorly to humans.
What "Exercise Mimetic" Doesn't Mean
The phrase makes for catchy headlines but oversells the compound. Real exercise produces a wide cascade of effects — cardiovascular adaptations, neurological changes, bone loading, balance and coordination improvements, and many systemic hormonal shifts. SLU-PP-332 does not reproduce most of those.
What it does reproduce is a slice of the gene-expression response, mostly in muscle and liver tissue. That slice can be useful in research models of metabolic disease, where exercise itself isn't always feasible. It is a research tool, not a substitute for movement.
Open questions include long-term safety, durability of effects, off-target receptor activity, and whether ERR activation in tissues outside muscle produces unwanted consequences. These compounds are sold strictly for in vitro laboratory research and are not approved for human consumption.